Dmitry Balyasny’s Guardant Health GH Stock Holding History

Dmitry Balyasny’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,600	Closed	-$3.43M	–	3121
2025 Q4	$3.43M	Buy	33,600 +14,100	+72%	+$1.26M	﹤0.01%	1593
2025 Q3	$1.22M	Sell	19,500 -10,400	-35%	-$566K	﹤0.01%	2036
2025 Q2	$1.56M	Buy	+29,900	New	+$1.34M	﹤0.01%	1861
2025 Q1	–	Sell	-6,900	Closed	-$211K	–	2962
2024 Q4	$211K	Sell	6,900 -91,200	-93%	-$2.57M	﹤0.01%	2514
2024 Q3	$2.25M	Buy	+98,100	New	+$2.78M	﹤0.01%	1618
2022 Q4	–	Sell	-110,400	Closed	-$5.94M	–	2940
2022 Q3	$5.94M	Buy	110,400 +85,400	+342%	+$4.38M	0.02%	914
2022 Q2	$1.01M	Sell	25,000 -329,000	-93%	-$16.3M	﹤0.01%	1745
2022 Q1	$23.4M	Buy	354,000 +340,000	+2,429%	+$23.3M	0.07%	365
2021 Q4	$1.4M	Buy	+14,000	New	+$1.45M	﹤0.01%	1359

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Dmitry Balyasny's GH Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Guardant Health (GH) in Q2 2026: 124,368 shares worth $18.7M. The stake represents 0.02% of the portfolio and ranks #754 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in GH as recently as Q4 2025.

Dmitry Balyasny first reported a position in GH in Q2 2020 and has held it in 21 quarters since. The position peaked at $53.4M in Q1 2022. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Dmitry Balyasny held 124,368 shares of Guardant Health worth $18.7M as of Q2 2026.
Guardant Health was a new Dmitry Balyasny position in Q2 2026.
Guardant Health made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #754 holding.
Dmitry Balyasny first reported a position in Guardant Health in Q2 2020 and has held it in 21 quarters since.
Dmitry Balyasny's Guardant Health position peaked at $53.4M in Q1 2022.
595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.